Hedge Fund Drug Patent Challenges In Doubt After Bass' Test
Hedge fund manager Kyle Bass' controversial campaign against drug patents appears all but over, and despite some victories at the Patent Trial and Appeal Board, a lack of apparent success betting...To view the full article, register now.
Already a subscriber? Click here to view full article